Skip to main content

Our Science Impacts Lives

Science and innovation are the lifeblood of our company. But we’re doing more than developing medicines that perform well in the lab—we’re elevating the current standard of care to bring greater benefits to our patients.

Published ~2,000 papers

AbbVie scientists in the medical research community published nearly 2,000 papers, allowing others to build on scientific knowledge we’ve developed.


Researching Areas of Unmet Medical Need

We’re constantly finding new ways to address patients’ most serious health issues. We concentrate our efforts on a core set of therapeutic areas—ones where we’ve proven our expertise, and where we feel we can have an even greater impact on disease and how it is managed.

Where We Operate

Eight State-of-the-Art R&D Centers:

Lake County, Illinois, US
Redwood City, California, US
Sunnyvale, California, US (Pharmacyclics)
South San Francisco, California, US
Cambridge, Massachusetts, US
Worcester, Massachusetts, US
Ludwigshafen, Germany
Tokyo, Japan

Technologies and Platforms

Bringing Better Solutions to Patients

By investing in groundbreaking technologies and platforms, our goal is to drive innovation within our pipeline and deliver better solutions to patients.


products with potential for new drug or indication approvals by the end of 2023

Our products

A Portfolio of Medicines

We aim to develop innovative therapies for health conditions where there is significant need. Our medicines are approved in individual countries for different uses around the globe.

Clinical Trials and Me

Make New Medicines Possible

Whether you or a relative are interested in participating in a trial, our Clinical Trials and Me website can help address your questions. It offers information about clinical trials and lists our current clinical trials. You’ll also learn how to prepare for one and what to expect during and after a clinical trial.